Skip to main content

Evidence-Based Supplement Research

Evidence-Based Supplement Research

Casein Protein and Reduced Systolic Blood Pressure

Doses used in studies

g/day: 50 (median 50, IQR 50–50) — 1 study

Time to effect

Median: 5.1 months · IQR 5.1 months–5.1 months · Range 5.1 months–5.1 months — Reported in 1 of 1 study

1 of 1 paper

A double-blind, randomized, crossover trial protocol of whole hemp seed protein and hemp seed protein hydrolysate consumption for hypertension.
- 2020-04-23
- RCT
- Trials 21(1)
- - Maryam Samsamikor
  - Dylan Mackay
  - Rebecca C Mollard
  - Rotimi E Aluko
- PubMed: 32326966
- DOI: 10.1186/s13063-020-4164-z
4 Insights on
- Reduced Systolic Blood Pressure
- High evidence
- Clinical
This trial protocol is designed to evaluate the hypotensive potential of consuming whole HSP, and HSP+, in comparison to casein protein.
Effect
Neutral
Effect size
Small
Significant
No
Dose
25 g twice a day